Atara Biotherapeutics, Inc. (ATRA) Ownership

$5.94

south_east
-$0.04 (-0.67%)
Day's range
$5.72
Day's range
$6.09

Atara Biotherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ECOR1 CAPITAL, LLC 02/14/2025 532,134 $7.08 M   13.48% 4.98%
REDMILE GROUP, LLC 02/14/2025 441,701 $5.88 M   -2.34% 4.13%
VESTAL POINT CAPITAL, LP 02/14/2025 125,000 $1.66 M   0.26% 1.17%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 124,473 $1.66 M   -3.62% 1.16%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 75,196 $1.00 M   0.00% 0.70%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 67,140 $893,633   -0.88% 0.63%
BLACKROCK, INC. 02/07/2025 60,846 $809,861   -0.18% 0.57%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 54,744 $728,811   17.17% 0.51%
STALEY CAPITAL ADVISERS INC 02/07/2025 50,000 $665,500   25.00% 0.47%
MARSHALL WACE, LLP 02/13/2025 24,958 $332,192   100.00% 0.23%
BIRCHVIEW CAPITAL, LP 02/14/2025 22,000 $292,820   100.00% 0.21%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 14,000 $186,340   0.00% 0.13%
MILLENNIUM MANAGEMENT LLC 02/14/2025 10,133 $134,870   -94.24% 0.09%
POINT72 ASIA (SINGAPORE) PTE. LTD. 02/14/2025 3,603 $47,956   100.00% 0.03%
02/06/2025 1,416 $18,847   100.00% 0.01%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 444 $5,000   244.19% 0.00%
01/23/2025 240 $3,194   100.00% 0.00%
JONES FINANCIAL COMPANIES LLLP 02/06/2025 203 $2,702   100.00% 0.00%
02/14/2025 176 $2,330   100.00% 0.00%
RHUMBLINE ADVISERS 01/30/2025 175 $2,329   0.00% 0.00%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 70 $932   -90.69% 0.00%
POINT72 (DIFC) LTD 02/14/2025 68 $905   100.00% 0.00%
GAMMA INVESTING LLC 01/03/2025 56 $745   0.00% 0.00%
EVERSOURCE WEALTH ADVISORS, LLC 02/10/2025 35 $466   0.00% 0.00%
02/13/2025 28 $373   100.00% 0.00%
CENTIVA CAPITAL, LP 02/14/2025 0 $0   -100.00% 0.00%
GLOBAL RETIREMENT PARTNERS, LLC 01/31/2025 0 $0   -100.00% 0.00%
02/10/2025 0 $0   -100.00% 0.00%

Atara Biotherapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 59 institutional investors and hedge funds held shares of Atara Biotherapeutics, Inc.. The most heavily invested institutionals were:

GAMMA Investing LLC: 0

EcoR1 Capital, LLC: 532,134

Redmile Group, LLC: 441,701

Vestal Point Capital, LP: 125,000

ACADIAN ASSET MANAGEMENT LLC: 124,473

TANG CAPITAL MANAGEMENT LLC: 75,196

21.92% of Atara Biotherapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 6.72 M shares in the last 24 months. This purchase volume represents approximately $39.93 M in transactions.